Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 28, 2016
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
[ Wed, Sep 28th 2016
] - WOPRAI
Brian Abrahams Maintained (SRPT) at Buy with Increased Target to $108 on, Sep 28th, 2016
Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $83 to $108 on, Sep 28th, 2016.
Brian has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mike Guo of "SunTrust Robinson Humphrey" Upgraded from Sell to Hold on, Monday, September 19th, 2016
This is the rating of the analyst that currently disagrees with Brian
- Yun Zhong of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Monday, September 19th, 2016
